MCM
AMED

Mazama Capital Management’s Amedisys AMED Stock Holding History

Mazama Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,702
Closed -$54K – 284
2014
Q3 		$54K Hold
2,702
– – 0.01% 215
2014
Q2 		$45K Buy
+2,702
New +$38.3K 0.01% 222

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mazama Capital Management's AMED Position: Q4 2014 in Review

Mazama Capital Management sold out of Amedisys (AMED) in Q4 2014, closing a stake of 2,702 shares — an estimated $54K sold.

Mazama Capital Management first reported a position in AMED in Q2 2014 and held it in 2 quarters. The position peaked at $54K in Q3 2014. 137 funds tracked by Wall St. Rank hold AMED as of Q4 2014.

  • Mazama Capital Management reported no remaining Amedisys position as of Q4 2014 after selling out during the quarter.
  • Mazama Capital Management sold 2,702 Amedisys shares in Q4 2014, an estimated $54K.
  • Mazama Capital Management first reported a position in Amedisys in Q2 2014 and held it in 2 quarters.
  • Mazama Capital Management's Amedisys position peaked at $54K in Q3 2014.
  • 137 funds tracked by Wall St. Rank held Amedisys as of Q4 2014.

Based on Mazama Capital Management's 13F filing for Q4 2014, filed 24 Feb 2015.